PPCB (Propanc Biopharma) 3-Year FCF Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PPCB Propanc Biopharma Inc PPCB
29 GF Score
Price $1.13
! 2 Warning Signs
View Full Analysis

What is Propanc Biopharma 3-Year FCF Growth Rate?

Propanc Biopharma PPCB -16.30% 29 3-Year FCF Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates PPCB with a GF Score™ of 29/100. The stock has 2 warning signs investors should review. Among 1,108 Biotechnology companies, Propanc Biopharma ranks worse than 90252.62% on this metric.

Propanc Biopharma's Free Cash Flow per Share for the three months ended in Mar. 2026 was $-1.27.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Propanc Biopharma  (NAS:PPCB) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Propanc Biopharma 3-Year FCF Growth Rate Related Terms

PPCB vs ARTL, GNPX, BCAB: 3-Year FCF Growth Rate Comparison

For the Biotechnology subindustry, Propanc Biopharma's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Propanc Biopharma 3-Year FCF Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Propanc Biopharma's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Propanc Biopharma's 3-Year FCF Growth Rate falls into.


PPCB
29GF Score
Propanc Biopharma Inc PPCB
3-Year FCF Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Propanc Biopharma 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Frequently Asked Questions Learn more about 3-Year FCF Growth Rate →
What does a 3-Year FCF Growth Rate of 0.00% mean?
Propanc Biopharma (PPCB) has a 3-Year FCF Growth Rate of 0.00% as of Mar. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Propanc Biopharma and its competitors. According to the industry distribution chart, Propanc Biopharma ranks #999999 out of 1108 companies in the Biotechnology industry.
Is Propanc Biopharma's 3-Year FCF Growth Rate too high?
Propanc Biopharma's current 3-Year FCF Growth Rate is 0.00%. Based on the distribution chart, Propanc Biopharma ranks #999999 out of 1108 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Propanc Biopharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Propanc Biopharma's 3-Year FCF Growth Rate compare to ARTL and GNPX?
According to the Biotechnology industry distribution chart, Propanc Biopharma ranks #999999 out of 1108 companies for 3-Year FCF Growth Rate. This places Propanc Biopharma in the lower half of its industry. The industry median 3-Year FCF Growth Rate is 19.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Biotechnology company?
The median 3-Year FCF Growth Rate among Biotechnology companies is 19.25, based on 1,108 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Propanc Biopharma and its competitors. For the Biotechnology industry, the median 3-Year FCF Growth Rate is 19.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Propanc Biopharma's current 3-Year FCF Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Propanc Biopharma stock overvalued right now?
Propanc Biopharma (PPCB) has a current 3-Year FCF Growth Rate of 0.00%. The current 3-Year FCF Growth Rate is 0.00%. Propanc Biopharma's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Propanc Biopharma (PPCB), the current 3-Year FCF Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Propanc Biopharma Business Description

Address 302, 6 Butler Street, Cambwerwell, VIC, AUS, 3124
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
29GF Score

Get the complete analysis for PPCB

3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price